The purpose of this transmittal is to inform facilities and providers about a change in the District of Columbia’s (DC’s) Suboxone and Buprenorphine-containing products daily dosing limit. Effective May 1, 2024, the daily dosing limit for Suboxone and Buprenorphine-containing products without a prior authorization will increase to 32mg. The current daily dosing limit is 24mg.